Theres also the danger of patients regaining the weight or, worse, suffering an AUD relapse when they either choose to go off the drug or have no choice but to go off, due to, say, an employment change and loss of insurance coverage for the medication
In Kenner, cost should not be a barrier to effective weight management solutions with semaglutide
Und wenn etwas einmal nicht sofort verfgbar ist
Overall, many had meaningful weight loss, but some individual results varied, according to the Cleveland Clinic: "Those treated for obesity lost an average of 8.4% of body weight before discontinuation and regained an average of 0.5% one year later Those treated for type 2 diabetes lost an average of 4.4% of body weight before discontinuation and lost an additional 1.3% of body weight one year later In the obesity group, 55% gained weight in the year after discontinuation, while 45% kept losing or stayed the same In the diabetes group, 44% gained weight, while 56% kept losing or stayed the same" There were two primary issues that led to patients stopping the medication, which were cost or insurance coverage, and side effects
